nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—GABRA2—conduct disorder	0.839	1	CbGaD
Midazolam—GABRA5—GABA A receptor activation—GABRA2—conduct disorder	0.00341	0.0228	CbGpPWpGaD
Midazolam—GABRA3—GABA A receptor activation—GABRA2—conduct disorder	0.00335	0.0224	CbGpPWpGaD
Midazolam—GABRB3—GABA A receptor activation—GABRA2—conduct disorder	0.00327	0.0218	CbGpPWpGaD
Midazolam—GABRR1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00325	0.0217	CbGpPWpGaD
Midazolam—GABRG2—GABA A receptor activation—GABRA2—conduct disorder	0.00321	0.0214	CbGpPWpGaD
Midazolam—GABRQ—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0031	0.0207	CbGpPWpGaD
Midazolam—GABRR2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0031	0.0207	CbGpPWpGaD
Midazolam—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.00281	0.0187	CbGpPWpGaD
Midazolam—GABRG3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00256	0.0171	CbGpPWpGaD
Midazolam—GABRB1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00252	0.0168	CbGpPWpGaD
Midazolam—GABRA6—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00238	0.0159	CbGpPWpGaD
Midazolam—GABRA4—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00235	0.0157	CbGpPWpGaD
Midazolam—GABRB2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00215	0.0144	CbGpPWpGaD
Midazolam—GABRA5—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00209	0.0139	CbGpPWpGaD
Midazolam—GABRA3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00205	0.0137	CbGpPWpGaD
Midazolam—GABRB3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.002	0.0134	CbGpPWpGaD
Midazolam—GABRG2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00197	0.0131	CbGpPWpGaD
Midazolam—GABRR1—GABA receptor activation—GABRA2—conduct disorder	0.00173	0.0115	CbGpPWpGaD
Midazolam—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00172	0.0115	CbGpPWpGaD
Midazolam—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00171	0.0114	CbGpPWpGaD
Midazolam—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00169	0.0113	CbGpPWpGaD
Midazolam—GABRQ—GABA receptor activation—GABRA2—conduct disorder	0.00165	0.011	CbGpPWpGaD
Midazolam—GABRR2—GABA receptor activation—GABRA2—conduct disorder	0.00165	0.011	CbGpPWpGaD
Midazolam—GABRG3—GABA receptor activation—GABRA2—conduct disorder	0.00136	0.00905	CbGpPWpGaD
Midazolam—GABRB1—GABA receptor activation—GABRA2—conduct disorder	0.00134	0.00891	CbGpPWpGaD
Midazolam—GABRA6—GABA receptor activation—GABRA2—conduct disorder	0.00126	0.00843	CbGpPWpGaD
Midazolam—GABRA4—GABA receptor activation—GABRA2—conduct disorder	0.00125	0.00833	CbGpPWpGaD
Midazolam—GABRB2—GABA receptor activation—GABRA2—conduct disorder	0.00114	0.00762	CbGpPWpGaD
Midazolam—GABRA5—GABA receptor activation—GABRA2—conduct disorder	0.00111	0.0074	CbGpPWpGaD
Midazolam—GABRA3—GABA receptor activation—GABRA2—conduct disorder	0.00109	0.00727	CbGpPWpGaD
Midazolam—GABRB3—GABA receptor activation—GABRA2—conduct disorder	0.00106	0.00709	CbGpPWpGaD
Midazolam—GABRG2—GABA receptor activation—GABRA2—conduct disorder	0.00104	0.00697	CbGpPWpGaD
Midazolam—CYP4B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000974	0.0065	CbGpPWpGaD
Midazolam—GABRQ—Orphan transporters—GABRA2—conduct disorder	0.00096	0.00641	CbGpPWpGaD
Midazolam—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.000912	0.00609	CbGpPWpGaD
Midazolam—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.000885	0.00591	CbGpPWpGaD
Midazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000794	0.0053	CbGpPWpGaD
Midazolam—GABRG3—Orphan transporters—GABRA2—conduct disorder	0.000791	0.00528	CbGpPWpGaD
Midazolam—GABRB1—Orphan transporters—GABRA2—conduct disorder	0.000779	0.0052	CbGpPWpGaD
Midazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000757	0.00505	CbGpPWpGaD
Midazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000757	0.00505	CbGpPWpGaD
Midazolam—GABRA6—Orphan transporters—GABRA2—conduct disorder	0.000737	0.00492	CbGpPWpGaD
Midazolam—GABRA4—Orphan transporters—GABRA2—conduct disorder	0.000728	0.00486	CbGpPWpGaD
Midazolam—GABRR1—Ion channel transport—GABRA2—conduct disorder	0.000706	0.00471	CbGpPWpGaD
Midazolam—Chlordiazepoxide—GABRA2—conduct disorder	0.000686	0.0735	CrCbGaD
Midazolam—GABRR2—Ion channel transport—GABRA2—conduct disorder	0.000674	0.0045	CbGpPWpGaD
Midazolam—GABRQ—Ion channel transport—GABRA2—conduct disorder	0.000674	0.0045	CbGpPWpGaD
Midazolam—GABRB2—Orphan transporters—GABRA2—conduct disorder	0.000666	0.00444	CbGpPWpGaD
Midazolam—GABRA5—Orphan transporters—GABRA2—conduct disorder	0.000647	0.00432	CbGpPWpGaD
Midazolam—Clorazepate—GABRA2—conduct disorder	0.000641	0.0687	CrCbGaD
Midazolam—GABRA3—Orphan transporters—GABRA2—conduct disorder	0.000635	0.00424	CbGpPWpGaD
Midazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000623	0.00416	CbGpPWpGaD
Midazolam—GABRB3—Orphan transporters—GABRA2—conduct disorder	0.00062	0.00414	CbGpPWpGaD
Midazolam—Clotiazepam—GABRA2—conduct disorder	0.000615	0.0659	CrCbGaD
Midazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000614	0.0041	CbGpPWpGaD
Midazolam—GABRG2—Orphan transporters—GABRA2—conduct disorder	0.000609	0.00406	CbGpPWpGaD
Midazolam—GABRR1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000597	0.00398	CbGpPWpGaD
Midazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000581	0.00388	CbGpPWpGaD
Midazolam—Alprazolam—GABRA2—conduct disorder	0.000581	0.0622	CrCbGaD
Midazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000574	0.00383	CbGpPWpGaD
Midazolam—Mazindol—SLC6A4—conduct disorder	0.000573	0.0614	CrCbGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000569	0.0038	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000569	0.0038	CbGpPWpGaD
Midazolam—Cinolazepam—GABRA2—conduct disorder	0.000566	0.0606	CrCbGaD
Midazolam—Quazepam—GABRA2—conduct disorder	0.000563	0.0603	CrCbGaD
Midazolam—UGT1A4—Phase II conjugation—COMT—conduct disorder	0.000557	0.00372	CbGpPWpGaD
Midazolam—GABRG3—Ion channel transport—GABRA2—conduct disorder	0.000555	0.0037	CbGpPWpGaD
Midazolam—GABRB1—Ion channel transport—GABRA2—conduct disorder	0.000546	0.00365	CbGpPWpGaD
Midazolam—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.000532	0.00355	CbGpPWpGaD
Midazolam—Flunitrazepam—GABRA2—conduct disorder	0.000532	0.057	CrCbGaD
Midazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000525	0.0035	CbGpPWpGaD
Midazolam—CYP4B1—Biological oxidations—COMT—conduct disorder	0.000521	0.00348	CbGpPWpGaD
Midazolam—CYP4B1—Biological oxidations—MAOA—conduct disorder	0.000517	0.00345	CbGpPWpGaD
Midazolam—GABRA6—Ion channel transport—GABRA2—conduct disorder	0.000517	0.00345	CbGpPWpGaD
Midazolam—CYP4B1—Metapathway biotransformation—COMT—conduct disorder	0.000514	0.00343	CbGpPWpGaD
Midazolam—GABRA4—Ion channel transport—GABRA2—conduct disorder	0.00051	0.00341	CbGpPWpGaD
Midazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00051	0.0034	CbGpPWpGaD
Midazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000501	0.00334	CbGpPWpGaD
Midazolam—Estazolam—GABRA2—conduct disorder	0.000497	0.0533	CrCbGaD
Midazolam—UGT1A4—NRF2 pathway—SLC6A4—conduct disorder	0.00049	0.00327	CbGpPWpGaD
Midazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000489	0.00326	CbGpPWpGaD
Midazolam—Halazepam—GABRA2—conduct disorder	0.000483	0.0518	CrCbGaD
Midazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00048	0.0032	CbGpPWpGaD
Midazolam—Adinazolam—GABRA2—conduct disorder	0.000473	0.0507	CrCbGaD
Midazolam—Fludiazepam—GABRA2—conduct disorder	0.000469	0.0503	CrCbGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000469	0.00313	CbGpPWpGaD
Midazolam—GABRB2—Ion channel transport—GABRA2—conduct disorder	0.000467	0.00312	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000462	0.00308	CbGpPWpGaD
Midazolam—Prazepam—GABRA2—conduct disorder	0.000458	0.049	CrCbGaD
Midazolam—GABRR1—Neuronal System—GABRA2—conduct disorder	0.000457	0.00305	CbGpPWpGaD
Midazolam—GABRA5—Ion channel transport—GABRA2—conduct disorder	0.000454	0.00303	CbGpPWpGaD
Midazolam—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.000449	0.003	CbGpPWpGaD
Midazolam—GABRA3—Ion channel transport—GABRA2—conduct disorder	0.000445	0.00297	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000443	0.00296	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000437	0.00292	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—GABRA2—conduct disorder	0.000436	0.00291	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—GABRA2—conduct disorder	0.000436	0.00291	CbGpPWpGaD
Midazolam—GABRB3—Ion channel transport—GABRA2—conduct disorder	0.000435	0.0029	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000431	0.00288	CbGpPWpGaD
Midazolam—GABRG2—Ion channel transport—GABRA2—conduct disorder	0.000427	0.00285	CbGpPWpGaD
Midazolam—Flurazepam—GABRA2—conduct disorder	0.000427	0.0457	CrCbGaD
Midazolam—Triazolam—GABRA2—conduct disorder	0.000426	0.0457	CrCbGaD
Midazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000419	0.0028	CbGpPWpGaD
Midazolam—Oxazepam—GABRA2—conduct disorder	0.000413	0.0443	CrCbGaD
Midazolam—Temazepam—GABRA2—conduct disorder	0.000408	0.0437	CrCbGaD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000402	0.00268	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000394	0.00263	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000383	0.00256	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000376	0.00251	CbGpPWpGaD
Midazolam—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.000373	0.00249	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000367	0.00245	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000361	0.00241	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—GABRA2—conduct disorder	0.000359	0.0024	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—GABRA2—conduct disorder	0.000354	0.00236	CbGpPWpGaD
Midazolam—Diazepam—GABRA2—conduct disorder	0.000339	0.0363	CrCbGaD
Midazolam—GABRA6—Neuronal System—GABRA2—conduct disorder	0.000335	0.00223	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—GABRA2—conduct disorder	0.00033	0.00221	CbGpPWpGaD
Midazolam—UGT1A4—Biological oxidations—COMT—conduct disorder	0.000326	0.00218	CbGpPWpGaD
Midazolam—UGT1A4—Biological oxidations—MAOA—conduct disorder	0.000324	0.00216	CbGpPWpGaD
Midazolam—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000322	0.00215	CbGpPWpGaD
Midazolam—UGT1A4—Metapathway biotransformation—COMT—conduct disorder	0.000321	0.00215	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000315	0.0021	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—GABRA2—conduct disorder	0.000302	0.00202	CbGpPWpGaD
Midazolam—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000294	0.00196	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—GABRA2—conduct disorder	0.000294	0.00196	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—GABRA2—conduct disorder	0.000288	0.00192	CbGpPWpGaD
Midazolam—GABRR1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000287	0.00192	CbGpPWpGaD
Midazolam—GABRR1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000285	0.0019	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—GABRA2—conduct disorder	0.000281	0.00188	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—GABRA2—conduct disorder	0.000276	0.00184	CbGpPWpGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000274	0.00183	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—COMT—conduct disorder	0.000274	0.00183	CbGpPWpGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000272	0.00182	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000272	0.00182	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00027	0.0018	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000246	0.00164	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000244	0.00163	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—GABRA2—conduct disorder	0.000242	0.00161	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000234	0.00156	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000234	0.00156	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000226	0.00151	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000224	0.00149	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000222	0.00148	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000221	0.00147	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—COMT—conduct disorder	0.00022	0.00147	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—MAOA—conduct disorder	0.000218	0.00146	CbGpPWpGaD
Midazolam—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000218	0.00145	CbGpPWpGaD
Midazolam—CYP4B1—brain—conduct disorder	0.000216	0.0869	CbGeAlD
Midazolam—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000213	0.00142	CbGpPWpGaD
Midazolam—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000213	0.00142	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—COMT—conduct disorder	0.00021	0.0014	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—COMT—conduct disorder	0.00021	0.0014	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—COMT—conduct disorder	0.00021	0.0014	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000209	0.00139	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—MAOA—conduct disorder	0.000208	0.00139	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—MAOA—conduct disorder	0.000208	0.00139	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—COMT—conduct disorder	0.000208	0.00139	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.000207	0.00138	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000206	0.00138	CbGpPWpGaD
Midazolam—GABRQ—brain—conduct disorder	0.0002	0.0807	CbGeAlD
Midazolam—CYP4B1—Metabolism—CGA—conduct disorder	0.000197	0.00132	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000193	0.00129	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00019	0.00127	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00019	0.00127	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000189	0.00126	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—COMT—conduct disorder	0.000184	0.00123	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000184	0.00123	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000183	0.00122	CbGpPWpGaD
Midazolam—Chlorprothixene—HTR2A—conduct disorder	0.000182	0.0195	CrCbGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000181	0.00121	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00018	0.0012	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00018	0.0012	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000178	0.00119	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000178	0.00119	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000177	0.00118	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000177	0.00118	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000176	0.00117	CbGpPWpGaD
Midazolam—GABRG3—brain—conduct disorder	0.000175	0.0707	CbGeAlD
Midazolam—GABRG2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000174	0.00116	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—COMT—conduct disorder	0.000173	0.00115	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000172	0.00115	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—MAOA—conduct disorder	0.000172	0.00115	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—COMT—conduct disorder	0.00017	0.00114	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—MAOA—conduct disorder	0.000169	0.00113	CbGpPWpGaD
Midazolam—GABRR1—brain—conduct disorder	0.000167	0.0674	CbGeAlD
Midazolam—GABRB2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000162	0.00108	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—COMT—conduct disorder	0.000161	0.00108	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—MAOA—conduct disorder	0.00016	0.00107	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—COMT—conduct disorder	0.000159	0.00106	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—MAOA—conduct disorder	0.000158	0.00105	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000158	0.00105	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—COMT—conduct disorder	0.000157	0.00105	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.000156	0.00104	CbGpPWpGaD
Midazolam—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.000155	0.00104	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000155	0.00103	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000152	0.00101	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000151	0.00101	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000151	0.00101	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00015	0.001	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000149	0.000992	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—COMT—conduct disorder	0.000145	0.000971	CbGpPWpGaD
Midazolam—GABRD—brain—conduct disorder	0.000145	0.0585	CbGeAlD
Midazolam—GABRB2—Neuronal System—MAOA—conduct disorder	0.000144	0.000964	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—COMT—conduct disorder	0.000141	0.000943	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—MAOA—conduct disorder	0.00014	0.000936	CbGpPWpGaD
Midazolam—GABRG1—brain—conduct disorder	0.00014	0.0564	CbGeAlD
Midazolam—GABRA6—brain—conduct disorder	0.000139	0.056	CbGeAlD
Midazolam—GABRA3—Neuronal System—COMT—conduct disorder	0.000139	0.000926	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—MAOA—conduct disorder	0.000138	0.00092	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—COMT—conduct disorder	0.000136	0.00091	CbGpPWpGaD
Midazolam—GABRB1—brain—conduct disorder	0.000135	0.0546	CbGeAlD
Midazolam—GABRB3—Neuronal System—COMT—conduct disorder	0.000135	0.000904	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—MAOA—conduct disorder	0.000135	0.000904	CbGpPWpGaD
Midazolam—GABRA5—brain—conduct disorder	0.000135	0.0544	CbGeAlD
Midazolam—GABRB3—Neuronal System—MAOA—conduct disorder	0.000135	0.000898	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—COMT—conduct disorder	0.000133	0.000888	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—MAOA—conduct disorder	0.000132	0.000882	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00013	0.000867	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00013	0.000867	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000129	0.000861	CbGpPWpGaD
Midazolam—GABRA3—brain—conduct disorder	0.000125	0.0506	CbGeAlD
Midazolam—UGT1A4—Metabolism—CGA—conduct disorder	0.000123	0.000824	CbGpPWpGaD
Midazolam—GABRA4—brain—conduct disorder	0.000122	0.0493	CbGeAlD
Midazolam—CYP2B6—Biological oxidations—COMT—conduct disorder	0.000116	0.000777	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—COMT—conduct disorder	0.000116	0.000776	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.000116	0.000772	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—MAOA—conduct disorder	0.000115	0.000771	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.000115	0.000766	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—COMT—conduct disorder	0.000114	0.000761	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—COMT—conduct disorder	0.000114	0.00076	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.000113	0.000756	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.000113	0.000754	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.000112	0.000751	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.000112	0.000749	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000111	0.000742	CbGpPWpGaD
Midazolam—GABRB2—brain—conduct disorder	0.000102	0.0412	CbGeAlD
Midazolam—GABRG2—brain—conduct disorder	0.000102	0.0412	CbGeAlD
Midazolam—SLC22A1—Neuronal System—COMT—conduct disorder	9.95e-05	0.000664	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	9.89e-05	0.00066	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—MAOA—conduct disorder	9.88e-05	0.000659	CbGpPWpGaD
Midazolam—GABRA2—brain—conduct disorder	9.34e-05	0.0377	CbGeAlD
Midazolam—GABRE—brain—conduct disorder	9.27e-05	0.0374	CbGeAlD
Midazolam—GABRA1—brain—conduct disorder	9.03e-05	0.0364	CbGeAlD
Midazolam—CYP4B1—Metabolism—COMT—conduct disorder	8.91e-05	0.000595	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—MAOA—conduct disorder	8.85e-05	0.000591	CbGpPWpGaD
Midazolam—SLC22A1—brain—conduct disorder	8.82e-05	0.0356	CbGeAlD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	8.58e-05	0.000573	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	7.94e-05	0.00053	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	7.93e-05	0.000529	CbGpPWpGaD
Midazolam—GABRB3—brain—conduct disorder	7.85e-05	0.0317	CbGeAlD
Midazolam—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	6.52e-05	0.000435	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CGA—conduct disorder	5.97e-05	0.000398	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—COMT—conduct disorder	5.57e-05	0.000372	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CGA—conduct disorder	5.55e-05	0.000371	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—MAOA—conduct disorder	5.54e-05	0.000369	CbGpPWpGaD
Midazolam—CYP2B6—brain—conduct disorder	5.32e-05	0.0215	CbGeAlD
Midazolam—CYP3A4—Biological oxidations—COMT—conduct disorder	5.29e-05	0.000353	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.25e-05	0.000351	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.22e-05	0.000348	CbGpPWpGaD
Midazolam—CYP2E1—brain—conduct disorder	5e-05	0.0202	CbGeAlD
Midazolam—CYP2B6—Metabolism—CGA—conduct disorder	4.41e-05	0.000294	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CGA—conduct disorder	4.32e-05	0.000288	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CGA—conduct disorder	4.31e-05	0.000288	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—EP300—conduct disorder	3.82e-05	0.000255	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	3.39e-05	0.000226	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CGA—conduct disorder	3.25e-05	0.000217	CbGpPWpGaD
Midazolam—ABCB1—brain—conduct disorder	2.85e-05	0.0115	CbGeAlD
Midazolam—CYP3A7—Metabolism—COMT—conduct disorder	2.69e-05	0.00018	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—MAOA—conduct disorder	2.67e-05	0.000178	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—COMT—conduct disorder	2.51e-05	0.000167	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—MAOA—conduct disorder	2.49e-05	0.000166	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—EP300—conduct disorder	2.39e-05	0.00016	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CGA—conduct disorder	2e-05	0.000134	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—COMT—conduct disorder	1.99e-05	0.000133	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—MAOA—conduct disorder	1.98e-05	0.000132	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—COMT—conduct disorder	1.95e-05	0.00013	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—COMT—conduct disorder	1.95e-05	0.00013	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—MAOA—conduct disorder	1.94e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—MAOA—conduct disorder	1.93e-05	0.000129	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—COMT—conduct disorder	1.47e-05	9.8e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MAOA—conduct disorder	1.46e-05	9.73e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—EP300—conduct disorder	1.15e-05	7.71e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—EP300—conduct disorder	1.07e-05	7.17e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—COMT—conduct disorder	9.05e-06	6.04e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MAOA—conduct disorder	8.99e-06	6e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—EP300—conduct disorder	8.54e-06	5.7e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—EP300—conduct disorder	8.36e-06	5.58e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—EP300—conduct disorder	8.35e-06	5.57e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—EP300—conduct disorder	6.3e-06	4.2e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—EP300—conduct disorder	3.88e-06	2.59e-05	CbGpPWpGaD
